European Antibiotic Awareness Day (EAAD): Media toolkit
European Antibiotic Awareness Day (EAAD is an annual European public health initiative that takes place on 18 November to raise awareness about the threat to public health of antibiotic resistance and the importance of prudent antibiotic use.
This toolkit brings together ECDC materials for EAAD 2026. Journalists and media organisations can use these resources to support reporting on antimicrobial resistance, antibiotic use, and this year’s campaign.
Key facts
- Each year, over 35 000 people in the European Union (EU) die from infections with microorganisms resistant to antimicrobials, a mortality comparable to that of influenza, tuberculosis and HIV/AIDS combined.
- Each year, 4.3 million patients in the EU/EEA acquire at least one healthcare-associated infection during their stay in a hospital.2
- 1 in 3 microorganisms detected in healthcare-associated infections are bacteria resistant to important antibiotics, thus limiting options for treating infections.
- In 2025, the estimated incidence of bloodstream infections of carbapenem-resistant Klebsiella pneumoniae (K. pneumoniae) for the EU/EEA increased by 72% compared to 2019. Infections with carbapenem-resistant Enterobacterales (CRE) such as K. pneumoniae and Escherichia coli (E. coli) pose a significant threat to patients as they are linked to high mortality.
- Several strains of multidrug resistant K. pneumoniae are now even resistant to several antibiotics that have been recently developed to treat CRE.
- New strains of Klebsiella pneumoniae combine multidrug resistance with greater ability to cause severe disease, making infections harder to treat and potentially more serious.
- Increased numbers of bloodstream infections with resistant bacteria were observed not only in AMR-pathogen combinations with an EU target, but also in many other bacteria and antimicrobial groups under surveillance.
- Over 70% of the health burden of antimicrobial resistance in the EU/EEA is due to healthcare-associated infections with multidrug-resistant bacteria, half of which could be prevented through stronger infection prevention and control measures.
- There was progress in 2025 in reducing antimicrobial consumption, but it remains insufficient towards the 2030 European Union antimicrobial consumption targets.
- Hospital consumption of antimicrobials within the WHO AWaRe Reserve group continued to increase in 2025, suggesting an increasing reliance on antimicrobials that should be reserved for the treatment of confirmed or suspected infections caused by multidrug-resistant organisms.
- 90% of total human consumption of antibiotics is in the community sector or outpatient settings. Infants and preschool-aged children are a key group most often exposed to antibiotics, though many common childhood infections do not require them.
Press release: Urgent action needed to safeguard the effectiveness of antibiotics
English (330.91 KB - PDF)European Antibiotic Awareness Day 2026 - Key messages
English (288.41 KB - PDF)EU AMR targets factsheet 2026
English (310.42 KB - PDF)Antimicrobial consumption in the EU/EEA (ESAC-Net) - 2025 - Summary
English (222.53 KB - PDF)Antimicrobial resistance in the EU/EEA (EARS-Net) - 2025 - Summary
English (254.23 KB - PDF)Download the PDF: Carbapenem-resistant Enterobacterales: a growing threat
English (4.21 MB - PDF)EAAD Country factsheets
English (7.92 MB - ZIP)Latest reports